SCHEMBL4087735

SCHEMBL4087735

COC(=O)c1cnc(N2CCN(Cc3ccccc3C(F)(F)F)CC2)s1

nearest known ligand 0.77

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SCD O00767 5/20 0.77
ALDH1A1 P00352 6/20 0.52
KDM4E B2RXH2 6/20 0.52
TDP1 Q9NUW8 3/20 0.52
NPSR1 Q6W5P4 3/20 0.52
ATM Q13315 3/20 0.52
GAA P10253 1/20 0.52
ALOX15 P16050 2/20 0.50
MAPT P10636 1/20 0.50
MEN1 O00255 6/20 0.49
KMT2A Q03164 6/20 0.49
LMNA P02545 1/20 0.48
TP53 P04637 1/20 0.48
POLB P06746 1/20 0.48
TSHR P16473 1/20 0.48
MAPK1 P28482 1/20 0.48
HTT P42858 1/20 0.48
EPHX2 P34913 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4101981 0.87 SCD (1.00) SCDALDH1A1KDM4ETDP1NPSR1
SCHEMBL4804346 0.82 ALDH1A1 (0.61) SCDALDH1A1MAPTMEN1KMT2A
SCHEMBL25348 0.81 SCD (0.80) SCD
SCHEMBL28614130 0.79 SCD (0.49) SCDALDH1A1KDM4EMAPTMEN1
SCHEMBL4859342 0.79 SCD (0.51) SCD
SCHEMBL472984 0.78 SCD (0.78) SCD
SCHEMBL4814724 0.76 HDAC3 (0.53) ALDH1A1MAPT
SCHEMBL4818519 0.75 HRH3 (0.50) SCD
SCHEMBL3159765 0.74 HRH3 (0.54) TDP1
SCHEMBL2946807 0.74 SCD (0.79) SCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090099200-A1 Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase MERCK FROSST CANADA LTD. (CA) 2009-04-16 US disclosed
US-20090099200-A1 Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase MERCK FROSST CANADA LTD. (CA) 2009-04-16 US disclosed
US-20090099200-A1 Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase MERCK FROSST CANADA LTD. (CA) 2009-04-16 US disclosed
EP-1902051-A1 AZACYCLOHEXANE DERIVATIVES AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE Merck Frosst Canada Ltd. (CA) 2008-03-26 EP disclosed
WO-2006130986-A1 AZACYCLOHEXANE DERIVATIVES AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK FROSST CANADA LTD. (CA) 2006-12-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090099200-A1 Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase SCD, SCD5, SREBF1 SCD 1/4885ALDH1A1 553/4885KDM4E 1009/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.